to result in loss of the start codon ( Figure 1A ). This vector induced hyperalgesia in normal rats, and epinephrinewas transfected into ES cells, and nine clones containing induced enhancement of tetrodotoxin-resistant Na ؉ the homologous integration were identified. Two were current (TTX-R I Na ) in cultured rat dorsal root ganglion injected into blastocysts to produce chimeric animals. (DRG) neurons, are inhibited by a PKC⑀-selective inThree chimeric males mated to C57BL/6J females transhibitor peptide. Our findings indicate that PKC⑀ regumitted the mutation through the germline. Heterozygous lates nociceptor function and suggest that PKC⑀ inhibprogeny were intercrossed, and offspring were typed itors could prove useful in the treatment of pain.
PKC⑀ Mutant Mice Show Decreased Epinephrinea reduced thermal hyperalgesia compared with wildtype littermates after epinephrine administration (Figure Induced and Acetic Acid-Associated Hyperalgesia
To study the role of PKC⑀ in mechanical and thermal 2B). Finally, when evaluated by the acetic acid writhing test (Bjorkman, 1995) , mutant mice demonstrated a signociceptor function, we first examined mice treated with epinephrine. Epinephrine-induced hyperalgesia and nificantly lower nociceptive score than wild-type animals ( Figure 2C ). nociceptor sensitization depend on both PKC and protein kinase A (PKA) (Khasar et al., 1999). We chose to use epinephrine rather than bradykinin, which also activates PKC, because epinephrine acts directly on the primary A Selective Inhibitor of PKC⑀ Decreases EpinephrineInduced Hyperalgesia in Rats afferent nociceptor (Khasar et al., 1999), whereas bradykinin can act indirectly (Andreev et al., 1995) . We then The studies above suggest that a defect in PKC⑀-mediated signal transduction accounts for reduced epinephcompared epinephrine-induced responses with responses induced by prostaglandin E2 (PGE 2 ) since PGE 2 -stimurine-induced hyperalgesia. These results were not due to a deficit in motor function since PKC⑀ mutant mice lated sensitization is mediated only by PKA (Taiwo and Levine, 1991 Intradermal injection of ⑀V1-2 in normal rats decreased the mechanical hyperalgesia produced by injection of epinephrine into the hindpaw ( Figure 3A) . There was no effect from a scrambled ⑀V1-2 peptide (Johnson et al., 1996). The magnitude of inhibition produced by ⑀V1-2 was similar to that produced by the PKC inhibitor bisindoylmaleimide I, which inhibits several PKC isozymes, including PKC⑀ (Toullec et al., 1991) . Administration of ⑀V1-2 had no effect on PGE 2 -induced hyperalgesia. These results strongly support the conclusion that absence of PKC⑀-mediated signaling in adult neurons is responsible for reduced epinephrine sensitivity in PKC⑀ mutant mice. Furthermore, since bisindoylmaleimide I was no more effective in inhibiting epinephrine hyperalgesia than the ⑀V1-2 peptide, it is likely that the PKC⑀ isozyme alone is responsible for the contribution of PKC to epinephrine-induced hyperalgesia.
PKC⑀ Inhibition Attenuates Enhancement of Tetrodotoxin-Resistant Sodium Current by Epinephrine
In DRG neurons, epinephrine enhances a tetrodotoxinresistant sodium current (TTX-R I Na ) (Khasar et al., 1999) whose activity is increased by agents that act directly on primary afferent nociceptors in vivo to produce hyperalgesia (Gold et al., 1996) . Bisindoylmaleimide I at- Figure  4E ). PKC⑀ immunoreactivity was also present in the peptide were administered 3 and 5.75 hr after NGF injection. Rats were then tested for mechanical hyperalgesia soma and process of cultured DRG neurons that express substance P (Figures 4H and 4I) . Therefore, PKC⑀ is 6 hr after receiving NGF. NGF decreased the nociceptive threshold by 38.3% Ϯ 3.6% (n ϭ 6) in rats injected with present in most DRG neurons and in fibers in the skin, as well as in cell bodies and processes of cultured nocithe inactive scrambled ⑀V1-2 peptide. In rats treated with the ⑀V1-2 peptide, NGF was less effective, decreasceptors. ing the nociceptive threshold by only 29.9% Ϯ 3.6% (n ϭ 6, p ϭ 0.04, Student's t test). These results indicate that PKC⑀ also contributes to NGF-mediated hyperalDiscussion gesia.
For more than a decade, PKC has been suggested to play a role in nociceptive signaling. We now demonstrate
PKC⑀ Expression in DRG Neurons
Since peripheral injection of ⑀V1-2 reduced epinephrine-, the necessary contribution of a specific isozyme of PKC to primary afferent nociceptor function. We found that carrageenan-, and NGF-induced hyperalgesia, we hypothesized that PKC⑀ in the peripheral terminals of DRG PKC⑀ is required for full expression of epinephrineinduced sensitivity to mechanical and thermal stimuli. neurons mediates this effect. That PKC⑀ is present in the ., 1999) . The ⑀V1-2 peptide reduced the effect of epinephrine on TTX-R I Na , indicating that TTX-R Woolf et al., 1994), the mechanisms involved are not known. Therefore, we tested the hypothesis that NGF-I Na is a target of PKC⑀ as well as PKA. Taken together, our findings suggest that PKC⑀ contributes to epinephrineinduced hyperalgesia is mediated by PKC⑀. We found that inhibition of PKC⑀ with the ⑀V1-2 peptide decreased induced hyperalgesia by enhancing TTX-R I Na in primary afferent nociceptors.
NGF-induced mechanical hyperalgesia in rats. Thus, these data provide the first evidence for a signal transOur findings also indicate that PKC⑀ is required for full expression of carrageenan-induced hyperalgesia. duction pathway that underlies NGF-induced hyperalgesia. This suggests a role for PKC⑀ in pain due to inflammation and is consistent with evidence linking epinephrine to
The finding that PKC⑀ immunoreactivity was present 
